Akso Health (AHG) Shares Outstanding (Weighted Average) (2017 - 2025)
Akso Health (AHG) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $855.3 million as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Shares Outstanding (Weighted Average) rose 504.37% year-over-year to $855.3 million, compared with a TTM value of $855.3 million through Mar 2025, up 504.37%, and an annual FY2025 reading of $855.3 million, up 504.37% over the prior year.
- Shares Outstanding (Weighted Average) was $855.3 million for Q1 2025 at Akso Health, up from $141.5 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $855.3 million in Q1 2025 and bottomed at $48.8 million in Q1 2021.
- Average Shares Outstanding (Weighted Average) over 5 years is $234.8 million, with a median of $68.6 million recorded in 2023.
- The sharpest move saw Shares Outstanding (Weighted Average) grew 15.07% in 2023, then soared 504.37% in 2025.
- Year by year, Shares Outstanding (Weighted Average) stood at $48.8 million in 2021, then grew by 22.06% to $59.6 million in 2022, then grew by 15.07% to $68.6 million in 2023, then skyrocketed by 106.3% to $141.5 million in 2024, then skyrocketed by 504.37% to $855.3 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for AHG at $855.3 million in Q1 2025, $141.5 million in Q1 2024, and $68.6 million in Q1 2023.